Pemphigus Vulgaris_s
Pemphigus vulgaris may be a rare autoimmune disorder that's characterised by painful blisters and erosions on the skin and mucous membranes, most ordinarily inside the mouth. Pemphigus vulgaris accounts for 70% of all pemphigus cases worldwide although it's extremely rare in New Zealand (about one case per million of the population). Pemphigus vulgaris affects people of all races, age, and sex. It most commonly appears between the ages of 30 and 60 years and is more common in Jews and Indians than in other races, presumably for genetic reasons. Drug-induced pemphigus is additionally recognised and is most frequently caused by penicillamine, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and cephalosporins. Pemphigus is usually triggered by
cancer (paraneoplastic pemphigus),
infection or trauma. Pemphigus vulgaris may be a rare autoimmune disease of the skin and affects around 3 people per 100,000 population. Pemphigus vulgaris may cause severe blistering of the skin and therefore the mucous membranes lining the mouth, nose, throat, eyes and genital area. Blisters develop in the upper layer of the skin and have a thin and fragile outer surface that breaks away easily leaving raw areas (erosions) that can be extensive and painful. Our
immune system makes antibodies to fight infection. Normally these antibodies do not attack our own body. However, in an autoimmune disorder, like pemphigus vulgaris, the system makes antibodies (autoantibodies) that employment against
tissues within the body.
High Impact List of Articles
-
Respiratory function following on-Pump versus off-pump coronary bypass grafting surgery
Mohamed Ali Bakry*, Mohamed Elhassaini Abdelghafar Yousef & Hisham Mohamed Mohamed Salem
Research Article: Clinical Practice
-
Respiratory function following on-Pump versus off-pump coronary bypass grafting surgery
Mohamed Ali Bakry*, Mohamed Elhassaini Abdelghafar Yousef & Hisham Mohamed Mohamed Salem
Research Article: Clinical Practice
-
Should chelation therapy be abandoned?
NV Solenkova and GA Lamas
Editorial: Clinical Practice
-
Should chelation therapy be abandoned?
NV Solenkova and GA Lamas
Editorial: Clinical Practice
-
Acknowledgements: Volume 7 Issue 3
Appendices: Clinical Practice
-
Acknowledgements: Volume 7 Issue 3
Appendices: Clinical Practice
-
Pharmacogenetics of antipsychotic treatment response and side effects
B Mackenzie, RP Souza, O Likhodi, AK Tiwari, CC Zai, J Sturgess and DJ Muller
Review Article: Clinical Practice
-
Pharmacogenetics of antipsychotic treatment response and side effects
B Mackenzie, RP Souza, O Likhodi, AK Tiwari, CC Zai, J Sturgess and DJ Muller
Review Article: Clinical Practice
-
Comparative efficacy of daily versus alternate-day dosing of atorvastatin in Type 2 diabetic patients
Molouk Hadjibabaie, Sanaz Vosough-Ghanbari, Mania Radfar, Kheirollah Gholami, Seyed Hamid Khoei, Manoochehr Nakhjavani, Manijeh Ahani and Mohammad Abdollahi
Research Article: Clinical Practice
-
Comparative efficacy of daily versus alternate-day dosing of atorvastatin in Type 2 diabetic patients
Molouk Hadjibabaie, Sanaz Vosough-Ghanbari, Mania Radfar, Kheirollah Gholami, Seyed Hamid Khoei, Manoochehr Nakhjavani, Manijeh Ahani and Mohammad Abdollahi
Research Article: Clinical Practice
Relevant Topics in Clinical